Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00732160 · ClinicalTrials.gov registry record · NA

Aldosterone and Glucose Homeostasis

A NA study, sponsored by Vanderbilt University.

Completed
Registry status
NA
Development phase
34
Enrollment target

NCT00732160 is a NA study that has completed, run by Vanderbilt University. The registered enrollment target is 34 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00732160, a NA study, has completed, sponsored by Vanderbilt University.

COMPLETED
Registry status
NA
Development phase
34 participants
Enrollment target

Study Summary

Determine the effect of aldosterone on how the body handles glucose (sugar).

Interventions

  • DRUG Aldosterone infusion (A)
  • DRUG Vehicle Infusion (V)
  • OTHER High Sodium Diet (HS)
  • OTHER Low Sodium Diet (LS)

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2008-09
Est. Completion 2013-12
Phase NA

Sponsor

Vanderbilt University

430 total trials

What the Registry Record Tells You About NCT00732160

The ClinicalTrials.gov registry entry for NCT00732160 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Aldosterone infusion (A) is the first listed.

NCT00732160 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00732160 about?

NCT00732160 is a clinical study titled "Aldosterone and Glucose Homeostasis". Determine the effect of aldosterone on how the body handles glucose (sugar).

What is the current status of trial NCT00732160?

This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2008-09. Estimated completion is 2013-12.

What interventions are being tested in trial NCT00732160?

The interventions under investigation include: Aldosterone infusion (A) (DRUG), Vehicle Infusion (V) (DRUG), High Sodium Diet (HS) (OTHER), Low Sodium Diet (LS) (OTHER).

Who is sponsoring clinical trial NCT00732160?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.